7:30 – 8:00 a.m.

“New treatment options in the management of Waldenström's macroglobulinemia: bendamustine, bortezomib, and beyond”

Justin Harder, MD

2nd Year Hem Onc Fellow

DCI Speaker Series:

8:10 – 9:00 am

“Promises and Challenges of RNAi Therapeutics”

Anil Sood, MD

Professor and Vice Chair

Translational Research

Department of Gynecologic Oncology and Reproductive Medicine

M.D. Anderson Cancer Center